{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:27:20Z","timestamp":1790008040722,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mutation analysis of proto-oncogene c-kit (c-kit) is advisable before starting treatment with tyrosine kinase inhibitors in dogs with mast cell tumor (MCT), including those with metastatic disease. Testing is usually performed on primary tumors, assuming that c-kit mutation status does not change in metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>To give an insight into the mutational processes and to make a recommendation on the use of c-kit mutational analysis in the clinical setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-one client-owned dogs with metastatic MCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dogs undergoing resection or biopsy for both primary and matched metastatic MCT were prospectively enrolled. Total RNA or DNA was extracted from primary MCT and corresponding metastases. Exons 8, 9, and 11 were amplified by PCR and sequenced. Genetic features between primary MCT and metastases were compared. Their correlation with clinicopathologic features was investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Concordance (mutated or wild-type) of mutational status, evaluable in 21 primary and matched metastatic (20 nodal and 1 splenic) MCTs, was 100%. Three new c-kit mutations were identified. No significant correlation was detected between c-kit mutation and clinicopathologic features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Proto-oncogene c-kit mutational status is conserved between any primary and its matched secondary tumor, suggesting that both can be used for c-kit mutational testing. Targeted therapies might be also used to treat metastatic disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12266","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T10:07:22Z","timestamp":1388052442000},"page":"547-553","source":"Crossref","is-referenced-by-count":24,"title":["Concordance of\n                    <i>c-kit<\/i>\n                    Mutational Status in Matched Primary and Metastatic Cutaneous Canine Mast Cell Tumors at Baseline"],"prefix":"10.1093","volume":"28","author":[{"given":"L.","family":"Marconato","sequence":"first","affiliation":[{"name":"Centro Oncologico Veterinario , Sasso Marconi, Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zorzan","sequence":"additional","affiliation":[{"name":"Dipartimento di Biomedicina Comparata e Alimentazione, Universita degli Studi di Padova , Legnaro,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Giantin","sequence":"additional","affiliation":[{"name":"Dipartimento di Biomedicina Comparata e Alimentazione, Universita degli Studi di Padova , Legnaro,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Di Palma","sequence":"additional","affiliation":[{"name":"Idexx Laboratories Italy srl , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cancedda","sequence":"additional","affiliation":[{"name":"Centro Oncologico Veterinario , Sasso Marconi, Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dacasto","sequence":"additional","affiliation":[{"name":"Dipartimento di Biomedicina Comparata e Alimentazione, Universita degli Studi di Padova , Legnaro,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"2026022001043580500_jvim12266-bib-0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1523-1747.1999.00488.x","article-title":"Clustering of activating mutations in c-kit's juxtamembrane coding region in canine mast cell neoplasms","volume":"112","author":"Ma","year":"1999","journal-title":"J Invest Dermatol"},{"key":"2026022001043580500_jvim12266-bib-0002","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0301-472X(98)00075-7","article-title":"Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit","volume":"27","author":"London","year":"1999","journal-title":"Exp Hematol"},{"key":"2026022001043580500_jvim12266-bib-0003","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-08-0067","article-title":"Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors","volume":"6","author":"Letard","year":"2008","journal-title":"Mol Cancer Res"},{"key":"2026022001043580500_jvim12266-bib-0004","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2460\/ajvr.2002.63.1718","article-title":"Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs","volume":"63","author":"Downing","year":"2002","journal-title":"Am J Vet Res"},{"key":"2026022001043580500_jvim12266-bib-0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1593\/neo.05622","article-title":"The role of c-KIT in tumorigenesis: Evaluation in canine cutaneous mast cell tumors","volume":"8","author":"Webster","year":"2006","journal-title":"Neoplasia"},{"key":"2026022001043580500_jvim12266-bib-0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1354\/vp.44-3-298","article-title":"Cellular proliferation in canine cutaneous mast cell tumors: Associations with c-KIT and its role in prognostication","volume":"44","author":"Webster","year":"2007","journal-title":"Vet Pathol"},{"key":"2026022001043580500_jvim12266-bib-0007","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-08-1860","article-title":"Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision","volume":"15","author":"London","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026022001043580500_jvim12266-bib-0008","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1939-1676.2008.0190.x","article-title":"Masitinib is safe and effective for the treatment of canine mast cell tumors","volume":"22","author":"Hahn","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026022001043580500_jvim12266-bib-0009","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdf252","article-title":"Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites","volume":"13","author":"Gancberg","year":"2002","journal-title":"Ann Oncol"},{"key":"2026022001043580500_jvim12266-bib-0010","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1200\/JCO.2004.00.117","article-title":"Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies","volume":"22","author":"Scartozzi","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026022001043580500_jvim12266-bib-0011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/annonc\/mdl038","article-title":"Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: Implications for treatment with EGFR-inhibitors","volume":"17","author":"Italiano","year":"2006","journal-title":"Ann Oncol"},{"key":"2026022001043580500_jvim12266-bib-0012","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcpa.2012.05.012","article-title":"Molecular phenotype in mammary tumours of queens: Correlation between primary tumour and lymph node metastasis","volume":"148","author":"Brunetti","year":"2013","journal-title":"J Comp Pathol"},{"key":"2026022001043580500_jvim12266-bib-0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1746-6148-8-219","article-title":"Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: Possible prognostic-predictive models and\/or stronghold for specific treatments?","volume":"8","author":"Beha","year":"2012","journal-title":"BMC Vet Res"},{"key":"2026022001043580500_jvim12266-bib-0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jsap.12069","article-title":"Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours","volume":"54","author":"Amagai","year":"2013","journal-title":"J Small Anim Pract"},{"key":"2026022001043580500_jvim12266-bib-0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1939-1676.2004.tb02644.x","article-title":"Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs","volume":"18","author":"Zavodovskaja","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026022001043580500_jvim12266-bib-0016","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12032-013-0522-y","article-title":"Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors","volume":"30","author":"Gao","year":"2013","journal-title":"Med Oncol"},{"key":"2026022001043580500_jvim12266-bib-0017","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1476-5829.2012.00341.x","article-title":"European consensus document on mast cell tumours in dogs and cats","volume":"10","author":"Blackwood","year":"2012","journal-title":"Vet Comp Oncol"},{"key":"2026022001043580500_jvim12266-bib-0018","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1939-1676.2009.0354.x","article-title":"Ultrasound-guided cytology of spleen and liver: A prognostic tool in canine cutaneous mast cell tumor","volume":"23","author":"Stefanello","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026022001043580500_jvim12266-bib-0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/030098588402100503","article-title":"Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs","volume":"21","author":"Patnaik","year":"1984","journal-title":"Vet Pathol"},{"key":"2026022001043580500_jvim12266-bib-0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0300985810386469","article-title":"Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior","volume":"48","author":"Kiupel","year":"2011","journal-title":"Vet Pathol"},{"key":"2026022001043580500_jvim12266-bib-0021","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tvjl.2011.10.027","article-title":"Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy","volume":"193","author":"Kobayashi","year":"2012","journal-title":"Vet J"},{"key":"2026022001043580500_jvim12266-bib-0022","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between KIT expression and KIT mutation in melanoma: A study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Modern Pathol"},{"key":"2026022001043580500_jvim12266-bib-0023","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1040638711425945","article-title":"c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: Correlations with post-surgical prognosis","volume":"24","author":"Giantin","year":"2012","journal-title":"J Vet Diagn Invest"},{"key":"2026022001043580500_jvim12266-bib-0024","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2026022001043580500_jvim12266-bib-0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5326\/JAAHA-MS-5621","article-title":"Cutaneous MCTs: Associations with spay\/neuter status, breed, body size, and phylogenetic cluster","volume":"47","author":"White","year":"2011","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026022001043580500_jvim12266-bib-0026","doi-asserted-by":"crossref","first-page":"941275","DOI":"10.1155\/2013\/941275","article-title":"Breed-predispositions to cancer in pedigree dogs","volume":"2013","author":"Dobson","year":"2013","journal-title":"ISRN Vet Sci"},{"key":"2026022001043580500_jvim12266-bib-0027","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1439-0442.2005.00726.x","article-title":"Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours","volume":"52","author":"Kiupel","year":"2005","journal-title":"J Vet Med A"},{"key":"2026022001043580500_jvim12266-bib-0028","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/vr.158.9.287","article-title":"Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours","volume":"158","author":"Murphy","year":"2006","journal-title":"Vet Rec"},{"key":"2026022001043580500_jvim12266-bib-0029","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004390100505","article-title":"Nomenclature for the description of human sequence variations","volume":"109","author":"den Dunnen","year":"2001","journal-title":"Hum Genet"},{"key":"2026022001043580500_jvim12266-bib-0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the iuxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002","journal-title":"Vet Pathol"},{"key":"2026022001043580500_jvim12266-bib-0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/j.tcam.2009.02.002","article-title":"Tyrosine kinase inhibitors in veterinary medicine","volume":"24","author":"London","year":"2009","journal-title":"Top Companion Anim Med"},{"key":"2026022001043580500_jvim12266-bib-0032","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.887927","article-title":"Metastasis results from preexisting variant cells within a malignant tumor","volume":"197","author":"Fidler","year":"1977","journal-title":"Science"},{"key":"2026022001043580500_jvim12266-bib-0033","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31802b3488","article-title":"Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma","volume":"31","author":"Katona","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2026022001043580500_jvim12266-bib-0034","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/path.2382","article-title":"Heterogeneity of kinase inhibitor resistance mechanisms in GIST","volume":"216","author":"Liegl","year":"2008","journal-title":"J Pathol"},{"key":"2026022001043580500_jvim12266-bib-0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1349-7006.2008.00782.x","article-title":"Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib","volume":"99","author":"Taniguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"2026022001043580500_jvim12266-bib-0036","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.humpath.2013.01.007","article-title":"Analysis of KIT expression and gene mutation in human acral melanoma: With a comparison between primary tumors and corresponding metastases\/recurrences","volume":"44","author":"Dai","year":"2013","journal-title":"Hum Pathol"},{"key":"2026022001043580500_jvim12266-bib-0037","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tvjl.2012.11.018","article-title":"Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: A retrospective cohort study","volume":"196","author":"Takeuchi","year":"2013","journal-title":"Vet J"},{"key":"2026022001043580500_jvim12266-bib-0038","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2026022001043580500_jvim12266-bib-0039","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00595-010-4477-8","article-title":"Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case","volume":"41","author":"Ando","year":"2011","journal-title":"Surg Today"},{"key":"2026022001043580500_jvim12266-bib-0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/DAD.0b013e31818acb1a","article-title":"Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: A series of 5 cases with molecular analysis","volume":"31","author":"Wang","year":"2009","journal-title":"Am J Dermatopathol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12266","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12266","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/547\/67006892\/jvim12266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/547\/67006892\/jvim12266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:04:44Z","timestamp":1771567484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/28\/2\/547\/8492547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12266","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,3,1]]}}}